Mai Xiaoying 4
4 · Twist Bioscience Corp · Filed Feb 9, 2022
Insider Transaction Report
Form 4
Mai Xiaoying
Director
Transactions
- Award
Director Stock Option (right to buy)
2022-02-07+10,588→ 10,588 totalExercise: $60.33Exp: 2029-07-22→ Common Stock (10,588 underlying) - Award
Director Stock Option (right to buy)
2022-02-07+973→ 973 totalExercise: $189.96Exp: 2031-02-02→ Common Stock (973 underlying) - Award
Common Stock
2022-02-07+13,539→ 13,539 total - Award
Director Stock Option (right to buy)
2022-02-07+11,297→ 11,297 totalExercise: $60.33Exp: 2030-02-03→ Common Stock (11,297 underlying)
Footnotes (1)
- [F1]Each equity is fully vested at the time of grant, but represent equity awards for prior annual meetings in 2019, 2020 and 2021 that the Company was not able to grant. If the grants had been made at the time of the prior annual meetings, each grant would have vested upon the earlier of (1) the 1 year anniversary of the date of grant or (2) the next annual meeting.